Filana Therapeutics (FLNA) Current Deferred Revenue (2010 - 2013)
Filana Therapeutics (FLNA) posted quarterly Current Deferred Revenue of $7.8 million for Q3 2013, little changed quarter-over-quarter from $7.8 million in Q2 2013.
Filana Therapeutics (FLNA) Current Deferred Revenue (2010 - 2013) Analysis & Trends
Filana Therapeutics' Current Deferred Revenue history runs 4 years deep, the most recent figure standing at $7.8 million for Q3 2013.
- In Q3 2013, Current Deferred Revenue changed N/A year-over-year to $7.8 million; the TTM figure through Sep 2013 stood at $7.8 million (changed N/A YoY), while the FY2012 annual figure was $7.8 million, down 28.13% from the prior year.
- Current Deferred Revenue for Q3 2013 stood at $7.8 million, roughly flat from $7.8 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $10.9 million in Q4 2010, with the low at $7.8 million in Q4 2012.
- The 4-year median for Current Deferred Revenue is $10.9 million (2010), against an average of $9.5 million.
- The sharpest annual moves came in 2011 and 2012: Current Deferred Revenue changed 0.0% in 2011, then declined 28.13% in 2012.
- Filana Therapeutics' Current Deferred Revenue stood at $10.9 million in 2010, then changed by 0.0% to $10.9 million in 2011, then slipped by 28.13% to $7.8 million in 2012, then changed by 0.0% to $7.8 million in 2013.
- Business Quant data shows FLNA's Current Deferred Revenue at $7.8 million in Q3 2013, $7.8 million in Q2 2013, and $7.8 million in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | Filana Therapeutics | 46.13 Mn | 46.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | 7.83 Mn |
| Jun 30, 2013 | 7.83 Mn |
| Mar 31, 2013 | 7.83 Mn |
| Dec 31, 2012 | 7.83 Mn |
| Mar 31, 2012 | 10.90 Mn |
| Dec 31, 2011 | 10.90 Mn |
| Sep 30, 2011 | 10.90 Mn |
| Jun 30, 2011 | 10.90 Mn |
| Dec 31, 2010 | 10.90 Mn |